A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs.
https://sciencebusiness.technewslit.com/?p=45117
#News #Press #Science #Business #Collaboration #Biotechnology #Algorithms #MachineLearning #Zebrafish #DrugDiscovery #ClincialTrials #Preclinical #ADHD #Neuroscience #Europe
